Hca Midwest Health-Research Medical Center

Kansas City, Missouri 66211

0 studies enrolling now · 2 studies all time

What they study most

B-Cell Malignancies, Multiple Myeloma

Studies at this site

• Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) — Running, not enrolling
• Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients — Completed